Loading…

Loading grant details…

Completed HORIZON European Commission

Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective

€3.69M EUR

Funder European Commission
Recipient Organization Hy2Care Bv
Country Netherlands
Start Date Oct 01, 2022
End Date Sep 30, 2024
Duration 730 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190135342
Grant Description

Hy2Care brings a regenerative Injectable Hydrogel, of joint- and cartilage-mimicking composition, that is used to treat damaged cartilage. The cartilage defects are easily filled with a syringe during a standard one time arthroscopy.

The hydrogel fill the defect, prevents ingrowth of scar tissue and allows the body to heal itself by creating true Hyaline cartilage, ensuring an optimal regenerated tissue.

The high-quality regeneration provides the basis for a long lasting repair, postponing or even preventing the onset of osteoarthritis. The gel binds covalently to the surrounding cartilage ensuring integration of the new tissue. Revalidation is fast as the cartilage regrowth follows the degradation of the gel.

The lasting repair not only prevents additional secondary treatments but also pain, disability and escalating follow-on costs. In submission of the last cut off of the EIC in october 2020 Hy2Care scored a 14.0 and recieved the seal of excellence.

All Grantees

Hy2Care Bv

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant